Detalhe da pesquisa
1.
Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.
Cell
; 160(5): 977-989, 2015 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-25723171
2.
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.
Nature
; 534(7605): 129-32, 2016 06 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27251290
3.
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.
Proc Natl Acad Sci U S A
; 111(45): E4869-77, 2014 Nov 11.
Artigo
Inglês
| MEDLINE | ID: mdl-25349422
4.
Pharmacological targeting of the pseudokinase Her3.
Nat Chem Biol
; 10(12): 1006-12, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25326665
5.
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M.
Nature
; 462(7276): 1070-4, 2009 Dec 24.
Artigo
Inglês
| MEDLINE | ID: mdl-20033049
6.
An Assessment of the Penile Squamous Cell Carcinoma Surfaceome for Biomarker and Therapeutic Target Discovery.
Cancers (Basel)
; 15(14)2023 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37509297
7.
Discovery of selective irreversible inhibitors for EGFR-T790M.
Bioorg Med Chem Lett
; 21(2): 638-43, 2011 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21208802
8.
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer.
Sci Transl Med
; 13(609): eabb3738, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34516823
9.
Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways.
J Clin Invest
; 116(8): 2208-2217, 2006 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16862215
10.
Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention.
Cancer Res
; 65(3): 879-86, 2005 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15705886
11.
Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer.
Clin Cancer Res
; 23(1): 204-213, 2017 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27370605
12.
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors.
Cancer Res
; 77(10): 2712-2721, 2017 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28363995
13.
Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors.
Oncogene
; 24(13): 2204-17, 2005 Mar 24.
Artigo
Inglês
| MEDLINE | ID: mdl-15735762
14.
Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
Breast Cancer Res
; 7(5): R708-18, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-16168116
15.
Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines.
Mol Oncol
; 9(1): 260-9, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25226813
16.
EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors.
Clin Cancer Res
; 21(17): 3913-23, 2015 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25948633
17.
Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2.
Cancer Res
; 75(15): 3139-46, 2015 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26048680
18.
Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer.
Cancer Discov
; 5(9): 960-971, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26036643
19.
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.
Nat Med
; 21(6): 560-2, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25939061
20.
Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma.
Clin Cancer Res
; 20(24): 6551-8, 2014 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25294908